Advanced Renal Cell Carcinoma clinical trials

Explore recruiting advanced renal cell carcinoma clinical trials.

Recruiting advanced renal cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Renal Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 2 Study of MK-6482 in Participants With Advanced Renal Cell Carcinoma

Ireland, Belgium, Netherlands, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-label, Randomized, Phase 3 Study of MK-6482 in Combination with Lenvatinib (MK-7902) vs Cabozantinib for Treatment in Participants with Advanced Renal Cell Carcinoma Who Have Progressed After Prior Anti-PD-1/L1 Therapy

Austria, Ireland, Belgium, Romania, Poland, Germany +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Open-label, Randomized, Phase 1/2 Study of Belzutifan in Combination with Palbociclib Versus Belzutifan Monotherapy in Participants with Advanced Renal Cell Carcinoma

Sweden, Poland, France, Germany, Italy, Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 1b, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI5752 in Combination with Axitinib in Subjects with Advanced Renal Cell Carcinoma

Spain, France

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

Spain, Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

CLINICAL AND HUMORAL IMPACT OF PRIMARY TUMOR ABLATION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH IMMUNOTHERAPY.THE ITALIC-RCC RANDOMIZED STUDY

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Advanced Renal Cell Carcinoma trials by city

Advanced Renal Cell Carcinoma clinical trials

Recruiting advanced renal cell carcinoma studies right now

Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

64Cu-GRIP B in Patients With Advanced Malignancies

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma

A Study of MGC026 in Participants With Advanced Solid Tumors

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)